50 results
424B5
OVID
Ovid Therapeutics Inc
15 Nov 23
Prospectus supplement for primary offering
4:11pm
to amending our amended and restated bylaws, the classified board, the size of our board, removal of directors, director liability, vacancies on our board … that the authorized number of directors may be changed only by resolution of our board of directors;
provide that our board of directors are classified
8-K
EX-99.1
mjbfndypc iscj4dq
2 Oct 23
Dawn of the neurotherapeutics era Dr. Jeremy Levin CEO & Chairman
12:15pm